Dipti Amin serves as Executive at Lineage Cell Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Dipti Amin has executed 1 insider transactions totaling $57.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 28, 2022 involved purchasing 35,000 shares valued at $57.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 28, 2022 | LCTX | $57.0K | Purchase | 35,000 | $1.63 | Discretionary |
Dipti Amin currently holds 35,000 shares of Lineage Cell Therapeutics, Inc. (LCTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dipti Amin has been a net buyer of LCTX stock. They have purchased $57.0K and sold $0 worth of shares.
Dipti Amin's most recent insider trade was on Mar 28, 2022, when they purchased 35,000 shares at $1.63 per share.
Get notified when new Form 4 filings are submitted